Representative Investments
A leading Chinese high-end CNC equipment company, exporting to over 30 countries and listed with a market capitalization exceeding 10 billion RMB.
Specializing in innovative drugs for cancer immunotherapy, with multiple international clinical trials approved.
A leader in energy storage system technology, partnering with multiple international energy giants.
A provider of industrial AI and cloud platform solutions, serving over 200 manufacturing companies.
Exited Investments
Listed on the Shanghai Stock Exchange's STAR Market in 2022, with an IPO market capitalization of 8.5 billion RMB.
Acquired by an international semiconductor giant in 2023, with a transaction value exceeding 3 billion RMB.
